Clinical Trial Update: The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and effectiveness of Zidovudine in HIV-infected pregnant women and their infants completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Pregnancy

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Pregnancy | Phase 3 | Status: COMPLETED